Sumitomo Pharma Co., Ltd. (4506.T)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Toru Kimura Ph.D.
|
President, CEO & Representative Director | -- | -- | 1960 |
|
Mr. Kimihiro Mizuno
|
Executive Officer Legal & Compliance and Intellectual Property | -- | -- | -- |
|
Dr. Megumi Maruyama
|
Vice President & Head of Corporate Communications | -- | -- | -- |
|
Katsuhiko Nishida
|
EO, SVP of S&M & Head of Japan BU Deputy | -- | -- | -- |
|
Shunji Kobayashi
|
Executive Officer of Human Resources | -- | -- | -- |
|
Mr. Isao Shimizu
|
Exec. Officer, Head of Reliability Assur. Div, Dep. Head of Japan BU & Gen. Supv. of Mfg. & Mktg. | -- | -- | -- |
|
Mr. Hideyuki Harada
|
Mng. Exe. Off. of Supply Chain Div., SVP, Hd. of Supply Chain Div. & Hd. of Japan Bus. Unit | -- | -- | -- |
|
Dr. Tsutomu Nakagawa Ph.D.
|
Managing Executive Officer & Director | -- | -- | 1968 |
|
Ms. Yumi Sato
|
Managing Exe. Officer of Vaccines and Adjuvants Biz Dev., Res. & Dev. Div. SVP and Head of R&D Div. | -- | -- | -- |
|
Mr. Motoyuki Sakai
|
EVP of Global Corp. Strategy, Fin. Admin, Ex. Aff., CG, Corp. Comm.; IT Mgmt & DA & Rep. Director | -- | -- | 1961 |
Sumitomo Pharma Co., Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Corporate Governance
Upcoming Events
January 29, 2027 at 6:30 AM UTC
Sumitomo Pharma Co., Ltd. Earnings Date
March 30, 2027 at 12:00 AM UTC
Ex-Dividend Date
Recent Events
Recent Events Information Not Available
